Overview

Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases

Status:
Terminated
Trial end date:
2021-10-28
Target enrollment:
Participant gender:
Summary
This study will examine potential factors in the aqueous humor that may contribute to the development or progression of macular edema or fibrosis (due to any underlying disease) in patients suffering from these conditions.
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins University
Peter A Campochiaro, MD
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate